Eleven Biotherapeutics reported $-807000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US $ 2727M 56M
Bristol Myers Squibb BMY:US $ 5386M 595M
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Intrexon XON:US $ -19.31M 5.71M
Merk MRK:US $ 6309M 1525M
Pfizer PFE:US $ 11328M 4083M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Ziopharm Oncology ZIOP:US $ -9.79M 2M